Sandra Norman

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. pmc Risk factors for lymphedema after breast cancer treatment
    Sandra A Norman
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Cancer Epidemiol Biomarkers Prev 19:2734-46. 2010
  2. pmc Hormone therapy and fatal breast cancer
    Sandra A Norman
    Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 19:440-7. 2010
  3. pmc Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms
    Sandra A Norman
    Department of Medicine, Division of Hematology Oncology, Center for Clinical Epidemiologyand Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Oncol 27:390-7. 2009
  4. ncbi request reprint Protection of mammography screening against death from breast cancer in women aged 40-64 years
    Sandra A Norman
    Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania, 801 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
    Cancer Causes Control 18:909-18. 2007
  5. ncbi request reprint Modifiable risk factors for breast cancer recurrence: what can we tell survivors?
    Sandra A Norman
    Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104 6021, USA
    J Womens Health (Larchmt) 16:177-90. 2007
  6. ncbi request reprint Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk
    Timothy R Rebbeck
    Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Cancer Epidemiol Biomarkers Prev 16:1318-20. 2007
  7. ncbi request reprint Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology
    Timothy R Rebbeck
    Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 904 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
    Cancer Epidemiol Biomarkers Prev 16:444-50. 2007
  8. ncbi request reprint A retrospective case-control study of the use of hormone-related supplements and association with breast cancer
    Timothy R Rebbeck
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Int J Cancer 120:1523-8. 2007
  9. ncbi request reprint Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients
    Angela DeMichele
    Division of Hematology Oncology, Department of Medicine, and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Cancer 97:2150-9. 2003
  10. ncbi request reprint Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States)
    Sandra A Norman
    Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania, 801 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
    Cancer Causes Control 17:921-9. 2006

Research Grants

  1. BREAST CANCER PATTERNS OF CARE AND MORBIDITY
    Sandra Norman; Fiscal Year: 2002
  2. BREAST CANCER PATTERNS OF CARE AND MORBIDITY
    Sandra Norman; Fiscal Year: 2007

Detail Information

Publications31

  1. pmc Risk factors for lymphedema after breast cancer treatment
    Sandra A Norman
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Cancer Epidemiol Biomarkers Prev 19:2734-46. 2010
    ..As cancer treatments evolve, it is important to reevaluate their effect on lymphedema risk in breast cancer survivors...
  2. pmc Hormone therapy and fatal breast cancer
    Sandra A Norman
    Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 19:440-7. 2010
    ..Using a population-based case-control design, we estimated incidence rate ratios of fatal breast cancer in postmenopausal hormone therapy (HT) users compared to non-users by type, duration, and recency of HT use...
  3. pmc Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms
    Sandra A Norman
    Department of Medicine, Division of Hematology Oncology, Center for Clinical Epidemiologyand Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Oncol 27:390-7. 2009
    ..To examine the incidence, degree, time course, treatment, and symptoms of lymphedema in breast cancer survivors...
  4. ncbi request reprint Protection of mammography screening against death from breast cancer in women aged 40-64 years
    Sandra A Norman
    Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania, 801 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
    Cancer Causes Control 18:909-18. 2007
    ..This study assessed the efficacy of community-based screening mammography in protecting against breast cancer death, asking whether age differences in efficacy persisted in the 1990s...
  5. ncbi request reprint Modifiable risk factors for breast cancer recurrence: what can we tell survivors?
    Sandra A Norman
    Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104 6021, USA
    J Womens Health (Larchmt) 16:177-90. 2007
    ....
  6. ncbi request reprint Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk
    Timothy R Rebbeck
    Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Cancer Epidemiol Biomarkers Prev 16:1318-20. 2007
  7. ncbi request reprint Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology
    Timothy R Rebbeck
    Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 904 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
    Cancer Epidemiol Biomarkers Prev 16:444-50. 2007
    ....
  8. ncbi request reprint A retrospective case-control study of the use of hormone-related supplements and association with breast cancer
    Timothy R Rebbeck
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Int J Cancer 120:1523-8. 2007
    ..Additional confirmatory studies are required to determine whether black cohosh could be used to prevent breast cancer...
  9. ncbi request reprint Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients
    Angela DeMichele
    Division of Hematology Oncology, Department of Medicine, and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Cancer 97:2150-9. 2003
    ....
  10. ncbi request reprint Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States)
    Sandra A Norman
    Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania, 801 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
    Cancer Causes Control 17:921-9. 2006
    ..We studied the benefit of modern mammography screening in community settings, evaluating age-related differences in rates of late-stage breast cancer detection...
  11. ncbi request reprint Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer
    Brian L Strom
    Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, 824 Blockley Hall, 423 Guardian Drive, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Contraception 69:353-60. 2004
    ..This study does not support an increased risk of breast cancer associated with the use of injectable or implantable progestin-only contraceptives in women aged 35 to 64...
  12. ncbi request reprint Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women
    Sandra A Norman
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Cancer Causes Control 14:933-43. 2003
    ..We examined breast cancer risk related to lifetime exposure to oral contraceptives (OCs) and hormone replacement therapy (HRT) in postmenopausal women...
  13. ncbi request reprint Validation of self-reported screening mammography histories among women with and without breast cancer
    Sandra A Norman
    Center for Clinical Epidemiology and Biostatistics and Department of Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia 19104 6021, USA
    Am J Epidemiol 158:264-71. 2003
    ..Therefore, odds ratios will likely be biased toward the null, underestimating screening efficacy...
  14. ncbi request reprint The intersection of cancer and aging: establishing the need for breast cancer rehabilitation
    Kathryn H Schmitz
    Division of Clinical Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 921 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA
    Cancer Epidemiol Biomarkers Prev 16:866-72. 2007
    ....
  15. ncbi request reprint Measuring screening intensity in case-control studies of the efficacy of mammography
    A Russell Localio
    Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, 19104 6021, USA
    Am J Epidemiol 164:272-81. 2006
    ..Assessing the effect of screening intensity in case-control studies of mammography is possible if principles and methods for misclassification and measurement error guide the analysis...
  16. ncbi request reprint Practical aspects of sharing controls between case-control studies
    Greta R Bunin
    Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Pharmacoepidemiol Drug Saf 14:523-30. 2005
    ..We discuss the practical advantages and challenges of sharing controls among two or more concurrently conducted case-control studies...
  17. ncbi request reprint Morbidity and mortality of colorectal carcinoma surgery differs by insurance status
    Rachel Rapaport Kelz
    Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Cancer 101:2187-94. 2004
    ....
  18. ncbi request reprint Lifetime recreational exercise activity and breast cancer risk among black women and white women
    Leslie Bernstein
    Department of Preventive Medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA
    J Natl Cancer Inst 97:1671-9. 2005
    ....
  19. ncbi request reprint Oral contraceptives and the risk of breast cancer
    Polly A Marchbanks
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, USA
    N Engl J Med 346:2025-32. 2002
    ..We conducted a population-based, case-control study to determine the risk of breast cancer among former and current users of oral contraceptives...
  20. ncbi request reprint Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma
    Janet R Daling
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer 95:2455-64. 2002
    ..However, the use of combined (estrogen and progestin) hormone replacement therapy (CHRT) also has increased during the last decade and may account in part for the increase in invasive lobular breast carcinoma...
  21. ncbi request reprint Projecting individualized absolute invasive breast cancer risk in African American women
    Mitchell H Gail
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Executive Plaza South Rm 8032, Bethesda, MD 20892 7244, USA
    J Natl Cancer Inst 99:1782-92. 2007
    ..We developed a model for projecting absolute risk of invasive breast cancer in African American women and compared its projections with those from the Breast Cancer Risk Assessment Tool...
  22. ncbi request reprint Hormone replacement therapy regimens and breast cancer risk(1)
    Linda K Weiss
    Population Studies and Prevention Program, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA
    Obstet Gynecol 100:1148-58. 2002
    ..Progestin administered in an uninterrupted regimen may be a contributing factor. Risk dissipates once use is discontinued...
  23. ncbi request reprint Do thyroid disorders increase the risk of breast cancer?
    Michael S Simon
    Division of Hematology and Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA
    Cancer Epidemiol Biomarkers Prev 11:1574-8. 2002
    ..There was no statistical interaction between thyroid disorders, thyroid treatments, and race, menopausal status, or parity. We found no association between thyroid disorders or their associated treatments and the risk of breast cancer...
  24. ncbi request reprint Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study
    Ronald T Burkman
    National Cancer Institute Surveillance, Epidemiology, and End Results Registry, Department of Obstetrics and Gynecology, Henry Ford Health System, Detroit, Michigan, USA
    Fertil Steril 79:844-51. 2003
    ..To determine the association between infertility drug use and invasive breast cancer in a population-based case-control study...
  25. ncbi request reprint Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years
    Janet R Daling
    Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 12:1175-81. 2003
    ....
  26. ncbi request reprint Reproductive factors and risk of breast carcinoma in a study of white and African-American women
    Giske Ursin
    Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, USA
    Cancer 101:353-62. 2004
    ....
  27. ncbi request reprint Risk of breast cancer associated with short-term use of oral contraceptives
    Suzanne G Folger
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Cancer Causes Control 18:189-98. 2007
    ..To estimate breast cancer risk associated with short-term (<6 months) oral contraceptive use, and explore variation in estimates by use characteristics and medical, menstrual, and reproductive history...
  28. ncbi request reprint Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years
    Kathleen E Malone
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Res 66:8297-308. 2006
    ....
  29. ncbi request reprint Racial differences in the familial aggregation of breast cancer and other female cancers
    Michael S Simon
    Division of Haematology and Oncology, Barbara Ann Karmanos Cancer Institute, 4100 John R, 4221 Hudson, Weber Cancer Research Building, Detroit, M1 48201, USA
    Breast Cancer Res Treat 89:227-35. 2005
    ..17 (1.22-3.85). In conclusion, these racially distinct aggregation patterns may reflect different modes of inheritance and/or environmental factors that impact cancer risk...
  30. ncbi request reprint The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results
    Polly A Marchbanks
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Ann Epidemiol 12:213-21. 2002
    ..This paper presents methods and operational results of a population-based case-control study examining the effects of oral contraceptive use on breast cancer risk among white and black women aged 35-64 years in five U.S. locations...
  31. ncbi request reprint Alcohol exposure and breast cancer: results of the women's contraceptive and reproductive experiences study
    Jill A McDonald
    National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health, 4770 Buford Highway Northeast, MS K22, Atlanta, GA 30341 3724, USA
    Cancer Epidemiol Biomarkers Prev 13:2106-16. 2004
    ..To explore associated biological outcomes and clarify the role of timing of exposure in the alcohol-breast cancer relationship...

Research Grants12

  1. BREAST CANCER PATTERNS OF CARE AND MORBIDITY
    Sandra Norman; Fiscal Year: 2002
    ....
  2. BREAST CANCER PATTERNS OF CARE AND MORBIDITY
    Sandra Norman; Fiscal Year: 2007
    ..Preliminary data from the parent study suggest that only longer follow-up can capture the interplay of time-dependent risks, ongoing treatment, and patient characterisitics that occur over a longer period of time. ..